Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC14H15N3O |
InChIKeyZIAFWOWTIWLQRR-UHFFFAOYSA-N |
CAS Registry130518-52-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | DE | - |